Review



fcγr cd16 32 blocking antibody 2 4 g2 bioxcell  (Bio X Cell)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Bio X Cell fcγr cd16 32 blocking antibody 2 4 g2 bioxcell
    Fcγr Cd16 32 Blocking Antibody 2 4 G2 Bioxcell, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 340 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fcγr cd16 32 blocking antibody 2 4 g2 bioxcell/product/Bio X Cell
    Average 96 stars, based on 340 article reviews
    fcγr cd16 32 blocking antibody 2 4 g2 bioxcell - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    96
    Bio X Cell fcγr cd16 32 blocking antibody 2 4 g2 bioxcell
    Fcγr Cd16 32 Blocking Antibody 2 4 G2 Bioxcell, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fcγr cd16 32 blocking antibody 2 4 g2 bioxcell/product/Bio X Cell
    Average 96 stars, based on 1 article reviews
    fcγr cd16 32 blocking antibody 2 4 g2 bioxcell - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    90
    Thermo Fisher fcγr-blocking mab cd16/32 antibody
    Fcγr Blocking Mab Cd16/32 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fcγr-blocking mab cd16/32 antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    fcγr-blocking mab cd16/32 antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    96
    Bio X Cell fcγr cd16 32 blocking antibody
    Fcγr Cd16 32 Blocking Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fcγr cd16 32 blocking antibody/product/Bio X Cell
    Average 96 stars, based on 1 article reviews
    fcγr cd16 32 blocking antibody - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    90
    Becton Dickinson blocking antibodies against fcγrs cd16/32 (fcγrii/iii
    Fc receptor engagement and signaling by CRP and its ligands. Fc receptors were blocked by 10 μg/mL F(ab’) 2 preparations of antibodies against specific receptors or combinations of receptors. RI (CD64), RII (CD32, clone 41H16), and <t>RII/III</t> <t>(CD16/32)</t> represent blocks against FcγRI‐III, and human Fc block acts against all receptors as a positive control. Counts of M2 macrophages were performed after 4 days of TEM after treatment with (a) PC + CRP ( n = 4 in triplicate, * p < 0.05) or (b) liposomes (lipid) alone or with CRP ( n = 5 in triplicate, * p < 0.01). (c) To measure activation of cells via FcR, the phosphorylation of SYK was measured by an In‐cell Western assay, here expressed as the percentage of the total SYK that was phosphorylated at position 323 (pSYK323) ( n = 5, * p < 0.05). (d) Cells were treated with or without liposomes in the presence of CRP or 10 μg of IVIG or both ( n = 5, * p < 0.001).
    Blocking Antibodies Against Fcγrs Cd16/32 (Fcγrii/Iii, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/blocking antibodies against fcγrs cd16/32 (fcγrii/iii/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    blocking antibodies against fcγrs cd16/32 (fcγrii/iii - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Jackson Immuno fcγr-blocking antibody α-cd16/32 (2.4g2)
    Fc receptor engagement and signaling by CRP and its ligands. Fc receptors were blocked by 10 μg/mL F(ab’) 2 preparations of antibodies against specific receptors or combinations of receptors. RI (CD64), RII (CD32, clone 41H16), and <t>RII/III</t> <t>(CD16/32)</t> represent blocks against FcγRI‐III, and human Fc block acts against all receptors as a positive control. Counts of M2 macrophages were performed after 4 days of TEM after treatment with (a) PC + CRP ( n = 4 in triplicate, * p < 0.05) or (b) liposomes (lipid) alone or with CRP ( n = 5 in triplicate, * p < 0.01). (c) To measure activation of cells via FcR, the phosphorylation of SYK was measured by an In‐cell Western assay, here expressed as the percentage of the total SYK that was phosphorylated at position 323 (pSYK323) ( n = 5, * p < 0.05). (d) Cells were treated with or without liposomes in the presence of CRP or 10 μg of IVIG or both ( n = 5, * p < 0.001).
    Fcγr Blocking Antibody α Cd16/32 (2.4g2), supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fcγr-blocking antibody α-cd16/32 (2.4g2)/product/Jackson Immuno
    Average 90 stars, based on 1 article reviews
    fcγr-blocking antibody α-cd16/32 (2.4g2) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher cd16/32 or fcγr block 93 antibody
    Fc receptor engagement and signaling by CRP and its ligands. Fc receptors were blocked by 10 μg/mL F(ab’) 2 preparations of antibodies against specific receptors or combinations of receptors. RI (CD64), RII (CD32, clone 41H16), and <t>RII/III</t> <t>(CD16/32)</t> represent blocks against FcγRI‐III, and human Fc block acts against all receptors as a positive control. Counts of M2 macrophages were performed after 4 days of TEM after treatment with (a) PC + CRP ( n = 4 in triplicate, * p < 0.05) or (b) liposomes (lipid) alone or with CRP ( n = 5 in triplicate, * p < 0.01). (c) To measure activation of cells via FcR, the phosphorylation of SYK was measured by an In‐cell Western assay, here expressed as the percentage of the total SYK that was phosphorylated at position 323 (pSYK323) ( n = 5, * p < 0.05). (d) Cells were treated with or without liposomes in the presence of CRP or 10 μg of IVIG or both ( n = 5, * p < 0.001).
    Cd16/32 Or Fcγr Block 93 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd16/32 or fcγr block 93 antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    cd16/32 or fcγr block 93 antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Fc receptor engagement and signaling by CRP and its ligands. Fc receptors were blocked by 10 μg/mL F(ab’) 2 preparations of antibodies against specific receptors or combinations of receptors. RI (CD64), RII (CD32, clone 41H16), and RII/III (CD16/32) represent blocks against FcγRI‐III, and human Fc block acts against all receptors as a positive control. Counts of M2 macrophages were performed after 4 days of TEM after treatment with (a) PC + CRP ( n = 4 in triplicate, * p < 0.05) or (b) liposomes (lipid) alone or with CRP ( n = 5 in triplicate, * p < 0.01). (c) To measure activation of cells via FcR, the phosphorylation of SYK was measured by an In‐cell Western assay, here expressed as the percentage of the total SYK that was phosphorylated at position 323 (pSYK323) ( n = 5, * p < 0.05). (d) Cells were treated with or without liposomes in the presence of CRP or 10 μg of IVIG or both ( n = 5, * p < 0.001).

    Journal: Immunity, Inflammation and Disease

    Article Title: Phosphocholine‐containing ligands direct CRP induction of M2 macrophage polarization independent of T cell polarization: Implication for chronic inflammatory states

    doi: 10.1002/iid3.112

    Figure Lengend Snippet: Fc receptor engagement and signaling by CRP and its ligands. Fc receptors were blocked by 10 μg/mL F(ab’) 2 preparations of antibodies against specific receptors or combinations of receptors. RI (CD64), RII (CD32, clone 41H16), and RII/III (CD16/32) represent blocks against FcγRI‐III, and human Fc block acts against all receptors as a positive control. Counts of M2 macrophages were performed after 4 days of TEM after treatment with (a) PC + CRP ( n = 4 in triplicate, * p < 0.05) or (b) liposomes (lipid) alone or with CRP ( n = 5 in triplicate, * p < 0.01). (c) To measure activation of cells via FcR, the phosphorylation of SYK was measured by an In‐cell Western assay, here expressed as the percentage of the total SYK that was phosphorylated at position 323 (pSYK323) ( n = 5, * p < 0.05). (d) Cells were treated with or without liposomes in the presence of CRP or 10 μg of IVIG or both ( n = 5, * p < 0.001).

    Article Snippet: The human Fc block, isotype controls, and blocking antibodies against FcγRs CD16/32 (FcγRII/III) and CD32 (FcγRII) were obtained from BD Pharmingen (San Diego, CA), against CD64 (FcγRI) from eBioscience (San Diego, CA), against the R131 variant of FcγRII (clone 41H16 hybridoma) from Dr. Ted Zipf (MD Anderson Cancer Center, Houston, TX, retired) and their F(ab’) 2 fragments purified (Pierce F(ab’) 2 Preparation kit, Thermo Scientific, Pittsburgh, PA) before addition at 10 μg per well.

    Techniques: Blocking Assay, Positive Control, Activation Assay, In-Cell ELISA

    Schematic of results from this study, showing the binding of CRP and PC activating FcγRI leading to SYK phosphorylation and a switch from an M1 to an M2 macrophage phenotype, while liposome (lipid) complexed with CRP signaling leads to the same outcome via FcγRII. Liposomes, alone or bound to CRP, lead to a Th1 response.

    Journal: Immunity, Inflammation and Disease

    Article Title: Phosphocholine‐containing ligands direct CRP induction of M2 macrophage polarization independent of T cell polarization: Implication for chronic inflammatory states

    doi: 10.1002/iid3.112

    Figure Lengend Snippet: Schematic of results from this study, showing the binding of CRP and PC activating FcγRI leading to SYK phosphorylation and a switch from an M1 to an M2 macrophage phenotype, while liposome (lipid) complexed with CRP signaling leads to the same outcome via FcγRII. Liposomes, alone or bound to CRP, lead to a Th1 response.

    Article Snippet: The human Fc block, isotype controls, and blocking antibodies against FcγRs CD16/32 (FcγRII/III) and CD32 (FcγRII) were obtained from BD Pharmingen (San Diego, CA), against CD64 (FcγRI) from eBioscience (San Diego, CA), against the R131 variant of FcγRII (clone 41H16 hybridoma) from Dr. Ted Zipf (MD Anderson Cancer Center, Houston, TX, retired) and their F(ab’) 2 fragments purified (Pierce F(ab’) 2 Preparation kit, Thermo Scientific, Pittsburgh, PA) before addition at 10 μg per well.

    Techniques: Binding Assay